Top Down Review of Healthcare and Biotech Stocks: Growth Opportunities in Biopharma and Genomics….Updates 12/20
Update-3 12/20/25….A recovery week for biotech with XBI up 0.24% at $123.43 after being down to the $119 level,, IBB u p0.46% at $170.20 after being down to $165,76. Many stocks were up big on Friday’ as the WH might be finished with DRUG PRICE negotiations.Some tariff breaks have...
Traders and Investors are Winning with Biotech Stocks…Update-1
Update-1 12/13/25..Biotechs hold for the week as rotation moves out of Tech stocks; The IBB is down 0.51% but up 28% YTD at $169.42; XBI is down o.23% up 36.7% YTD at $123; ARKG down 2.36%, up 27.37% YTD at $30.20. Small cap performance also bodes well for SMID biotechs with IWM up 3% MTD. The...
Biotech Stocks Cruise to New Highs While Boosting Healthcare Sector…Update-3 DEC 5…alert
Update-3 12/5/25…3:15 PST…EYPT still strong up another 5%;.ADPT down another big 14%-Benziga has a note on a Natera buyout that must be related to drop in ADPT stock. More later but more competition is coming to blood cancers so watch ASH-American Society for Hematology coming up...
Biotech Deals Propel Sector to New 2025 Highs…Update-4…A bullish signal for upcoming week 11/23.
11/24/25…Update-4—11:00a EST—–GREEN SCREEN DAY in early trading with both IBB and XBI at new 2025 highs, laggard ARKG catching up at $29.34 up over 3%. Many 4% movers from our trading list—DNTH new buy, ADPT, ABOS, DNLI, GH, PACB, RYTM,TXG,TEM, and XNCR at a new...
Large Cap Biopharmaceuticals Lead the Way for Healthcare Investors…Update-1
Update-1 11/15 Merck buys Cedara for $9.2B for long acting Flu drug. An alternative to vaccines? CDTX up 105% IBB at $164.30 approaching highs of AUG 2021 of $177. Large Cap Biopharma Stocks Lead the Way for Healthcare Investors Biopharma stocks offer growth plus value with dividends.Standouts...